» Articles » PMID: 24448744

The Development of an Automated and GMP Compliant FASTlab™ Synthesis of [(18) F]GE-180; a Radiotracer for Imaging Translocator Protein (TSPO)

Overview
Date 2014 Jan 23
PMID 24448744
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The level of the translocator protein (TSPO) increases dramatically in microglial cells when the cells are activated in response to neuronal injury and insult. The radiotracer [(18) F]GE-180 binds selectively and with high affinity to TSPO and can therefore be used to measure neuroinflammation in a variety of disease states. An optimized, automated synthesis of [(18) F]GE-180 has been developed for the GE FASTlab™ synthesizer. The entire process takes place on the single-use cassette. The radiolabelling is performed by nucleophilic fluorination of the S- enantiomer mesylate precursor. The crude product is purified post-radiolabelling using two solid-phase extraction cartridges integrated on the cassette. Experimental design and multivariate data analysis were used to assess the robustness, and critical steps were optimized with respect to efficacy and quality. The average radiochemical yield is 48% (RSD 6%, non-decay corrected), and the synthesis time including purification is approximately 43 min. The radiochemical purity is ≥95% for radioactive concentration ≤1100 MBq/mL. The total amount of precursor-related chemical impurities is 1-2 µg/mL. The use of solid-phase extraction purification results in a robust GMP compliant process with a product of high chemical and radiochemical purity and consistent performance across positron emission tomography (PET) centers.

Citing Articles

Western diet increases brain metabolism and adaptive immune responses in a mouse model of amyloidosis.

Poxleitner M, Hoffmann S, Berezhnoy G, Ionescu T, Gonzalez-Menendez I, Maier F J Neuroinflammation. 2024; 21(1):129.

PMID: 38745337 PMC: 11092112. DOI: 10.1186/s12974-024-03080-0.


Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [F]FET PET, and TSPO PET.

Kaiser L, Quach S, Zounek A, Wiestler B, Zatcepin A, Holzgreve A Eur J Nucl Med Mol Imaging. 2024; 51(8):2371-2381.

PMID: 38396261 PMC: 11178656. DOI: 10.1007/s00259-024-06654-5.


Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities.

Baglini E, Poggetti V, Cavallini C, Petroni D, Forini F, Nicolini G J Med Chem. 2023; 67(1):17-37.

PMID: 38113353 PMC: 10911791. DOI: 10.1021/acs.jmedchem.3c01716.


Astrocytes: Lessons Learned from the Cuprizone Model.

Kipp M Int J Mol Sci. 2023; 24(22).

PMID: 38003609 PMC: 10671869. DOI: 10.3390/ijms242216420.


A feasibility study for quantitative assessment of cerebrovascular malformations using flutriciclamide ([F]GE-180) PET/MRI.

Kim S, Lupo J, Chen Y, Pampaloni M, VanBrocklin H, Narvid J Front Med (Lausanne). 2023; 10:1091463.

PMID: 37089589 PMC: 10116613. DOI: 10.3389/fmed.2023.1091463.